Brazil’s pharmaceutical market access environment is evolving rapidly. Recent updates to the CMED pricing framework are reshaping how companies approach pricing, launch planning, and commercialization strategies in Brazil.
In this on-demand webinar recording, our experts discuss the latest regulatory developments and what they mean for pharmaceutical companies navigating the Brazilian market access landscape.
This recording covers:
- The most important changes introduced by the new CMED pricing resolution
- Which regulatory updates are still pending and expected next
- Strategic implications for pricing, reimbursement, and product launches in Brazil
- How evolving CMED dynamics are influencing market access decision-making
Watch this free on-demand webinar to gain actionable insights and better understand how to anticipate risks and identify opportunities in Brazil’s changing access environment.
